Carlsmed (CARL) Non-Current Debt (2024 - 2026)

Carlsmed's (CARL) quarterly Non-Current Debt came in at $15.4 million in Q1 2026, little changed on a QoQ basis from $15.3 million in Q4 2025.

Carlsmed (CARL) Non-Current Debt (2024 - 2026) Analysis & Trends

Carlsmed (CARL) has 3 years of Non-Current Debt data on file, last reported at $15.4 million in Q1 2026.

Quarterly Non-Current Debt changed N/A year-over-year to $15.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.4 million (changed N/A YoY) and the FY2025 annual result came in at $15.3 million, changed 0.44% from the prior year.
Non-Current Debt was little changed at $15.4 million in Q1 2026, from $15.3 million in the prior quarter.
In the past five years, Non-Current Debt ranged from a high of $15.4 million in Q3 2025 to a low of $15.3 million in Q4 2025.
A 3-year average of $15.4 million and a median of $15.4 million in 2024 frame the typical range for Non-Current Debt.
The widest YoY moves for Non-Current Debt: up 0.44% in 2025, down 0.44% in 2025.
Tracing CARL's Non-Current Debt over 3 years: stood at $15.4 million in 2024, then retreated by 0.44% to $15.3 million in 2025, then increased by 0.12% to $15.4 million in 2026.
The last three Non-Current Debt figures came in at $15.4 million (Q1 2026), $15.3 million (Q4 2025), and $15.4 million (Q3 2025), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Non-Current Debt (Qtr)
1	Veeva Systems	39.72 Bn	32.40 Bn	662.02 Mn	-
2	BrightSpring Health Services	12.19 Bn	11.64 Bn	492.75 Mn	2.15 Bn
3	Healthequity	8.79 Bn	8.52 Bn	256.31 Mn	942.66 Mn
4	10x Genomics	7.31 Bn	6.76 Bn	112.50 Mn	-
5	Hinge Health	7.10 Bn	6.71 Bn	183.95 Mn	-
6	MiniMed	5.66 Bn	5.36 Bn	480.00 Mn	-
7	Waystar Holding	4.76 Bn	4.56 Bn	221.99 Mn	1.45 Bn
8	Doximity	4.46 Bn	3.77 Bn	132.93 Mn	-
9	Heartflow	3.66 Bn	3.28 Bn	53.19 Mn	-
10	Carlsmed	389.87 Mn	276.57 Mn	14.54 Mn	15.38 Mn

Download Data